Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
53.06
+0.65 (1.24%)
At close: May 20, 2026, 4:00 PM EDT
53.15
+0.09 (0.17%)
Pre-market: May 21, 2026, 4:33 AM EDT

Royalty Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
468.261,3241,3311,700--
Depreciation & Amortization
1.173.85----
Stock-Based Compensation
121.99289.892.342.36--
Other Adjustments
-708.37-2,466-1,601-1,921--
Changes in Accounts Payable
-5.08-13.93-2.296.24--
Changes in Accrued Expenses
-85.528.9346.38-2.48--
Changes in Other Operating Activities
3,5382,4782,7782,9892,1442,018
Operating Cash Flow
2,6122,4902,7692,9882,1442,018
Operating Cash Flow Growth
-3.28%-10.08%-7.32%39.36%6.27%-0.84%
Purchases of Investments
-2,592-2,202-2,822-2,140-2,575-3,647
Proceeds from Sale of Investments
48.06566.5118.3625.831,5461,776
Payments for Business Acquisitions
-74.23-74.42----
Other Investing Activities
111.1996.225.6841.84-0.52
Investing Cash Flow
-2,596-1,614-2,678-2,073-1,029-1,870
Short-Term Debt Issued
-1,275-350--
Short-Term Debt Repaid
--1,275--350--
Long-Term Debt Issued
1,9541,9541,471--1,273
Long-Term Debt Repaid
--1,000--1,000--
Net Long-Term Debt Issued (Repaid)
1,954954.481,471-1,000-1,273
Repurchase of Common Stock
-568.7-1,227-229.65-304.76--
Net Common Stock Issued (Repurchased)
-568.7-1,227-229.65-304.76--
Common Dividends Paid
-387.39-378.25-376.47-358.33-333.32-285.18
Other Financing Activities
-515.73-534.81-503.97-485.67-611.53-602.24
Financing Cash Flow
-517.34-1,186361.15-2,149-944.86385.11
Net Cash Flow
-501.33-310.33452.02-1,234169.7532.37
Free Cash Flow
2,6122,4902,7692,9882,1442,018
Free Cash Flow Growth
4.91%-10.08%-7.32%39.36%6.27%-0.84%
FCF Margin
107.02%104.69%122.33%126.89%95.83%88.12%
Free Cash Flow Per Share
4.974.414.664.964.904.86
Levered Free Cash Flow
6,2304,2025,1533,1282,1873,910
Unlevered Free Cash Flow
5,0374,0364,1154,4852,4513,448
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q